FIELD: medicine pharmaceutics.SUBSTANCE: per oral pharmaceutical drug form in composition of which included are at least two medical substances in from of separately preliminarily formed pills. In claimed form medicinal substances from one side are together in hermetically in vivo water-soluble wrapping or coating and from the other side are separated in such a way that active agents of combined medicinal substances cannot contact with each other. At least one of medications is selected from the following groups of therapeutic medications: non-steroidal anti-inflammatory preparation (NAIP) inhibitor of proton pump (IPP) beta-blocker statin conversion enzyme inhibitor (CEI) biguanide neuromuscular blocking agent calcium inhibitor corticoid antidepressant benzodiazepine inhibitor of intestinal transit of non-atropine-like action intestinal antibacterial medication and following therapeutic molecules: spironolactone propranolol clarithromycin amoxicillin low dose acetylsalicylic acid potassium clopidogrel.EFFECT: pharmaceutical drug form by invention ensures patient with one drug form for several medicinal preparations which makes it possible to avoid separate introduction of medicinal preparations.21 cl 7 dwg

暂无附图